Bile duct adenocarcinoma
Also known as: Cholangiocarcinoma (morphologic abnormality) / Bile duct cancer / Bile duct cancer NOS / Bile duct carcinoma / Carcinoma bile duct / Intrahepatic bile duct carcinoma / Cholangiosarcoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract (disorder) / Cholangiocarcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01101 | Capecitabine | 1 | Withdrawn | 1 |
| DB13076 | Yttrium Y-90 | 1 | Withdrawn | 1 |
| DB16680 | Cadonilimab | 2 | Recruiting | 1 |
| DB09074 | Olaparib | 2 | Recruiting | 1 |
| DB15106 | Surufatinib | 2 | Recruiting | 1 |